Based on in vivo experiments conducted in mice and the analysis of clinical samples, it is suggested that LINK‐A can be exploited as a valuable and efficacious therapeutic target for obesity induced by HFD (Figure 8n). The gene discussed is LINC01139; the disease is obesity due to melanocortin 4 receptor deficiency.